These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 3978632

  • 1. Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line.
    Levine RM, Rubalcaba E, Lippman ME, Cowan KH.
    Cancer Res; 1985 Apr; 45(4):1644-50. PubMed ID: 3978632
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.
    Dubik D, Dembinski TC, Shiu RP.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6517-21. PubMed ID: 3677090
    [Abstract] [Full Text] [Related]

  • 6. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov 15; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 7. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M, Bolan G, Huff K.
    Cancer Treat Rep; 1976 Oct 15; 60(10):1421-9. PubMed ID: 1035504
    [Abstract] [Full Text] [Related]

  • 8. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells.
    Frankel LB, Lykkesfeldt AE, Hansen JB, Stenvang J.
    Breast Cancer Res Treat; 2007 Aug 15; 104(2):165-79. PubMed ID: 17061041
    [Abstract] [Full Text] [Related]

  • 9. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK, Boldt DH, Estrada P.
    Cancer Res; 1984 Apr 15; 44(4):1433-9. PubMed ID: 6704960
    [Abstract] [Full Text] [Related]

  • 10. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR, Murphy LC, Hall RE, Sutherland RL.
    Cancer Res; 1985 Apr 15; 45(4):1525-31. PubMed ID: 3978620
    [Abstract] [Full Text] [Related]

  • 11. Regulation of dihydrofolate reductase gene transcription in methotrexate-resistant mouse fibroblasts.
    Wu JS, Johnson LF.
    J Cell Physiol; 1982 Feb 15; 110(2):183-9. PubMed ID: 6279683
    [Abstract] [Full Text] [Related]

  • 12. Genetic instability and the development of steroid hormone insensitivity in cultured T 47D human breast cancer cells.
    Reddel RR, Alexander IE, Koga M, Shine J, Sutherland RL.
    Cancer Res; 1988 Aug 01; 48(15):4340-7. PubMed ID: 3390830
    [Abstract] [Full Text] [Related]

  • 13. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 14. Cyclin D1 expression is dependent on estrogen receptor function in tamoxifen-resistant breast cancer cells.
    Kilker RL, Hartl MW, Rutherford TM, Planas-Silva MD.
    J Steroid Biochem Mol Biol; 2004 Sep 01; 92(1-2):63-71. PubMed ID: 15544931
    [Abstract] [Full Text] [Related]

  • 15. Molecular mechanisms of resistance to antifolates, a review.
    Banerjee D, Ercikan-Abali E, Waltham M, Schnieders B, Hochhauser D, Li WW, Fan J, Gorlick R, Goker E, Bertino JR.
    Acta Biochim Pol; 1995 Sep 01; 42(4):457-64. PubMed ID: 8852336
    [Abstract] [Full Text] [Related]

  • 16. Relationship between the expression of estrogen-regulated genes and estrogen-stimulated proliferation of MCF-7 mammary tumor cells.
    Aitken SC, Lippman ME, Kasid A, Schoenberg DR.
    Cancer Res; 1985 Jun 01; 45(6):2608-15. PubMed ID: 3986799
    [Abstract] [Full Text] [Related]

  • 17. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB, McIvor RS.
    J Pharmacol Exp Ther; 1993 Nov 01; 267(2):989-96. PubMed ID: 8246174
    [Abstract] [Full Text] [Related]

  • 18. Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture.
    Aitken SC, Lippman ME.
    Cancer Res; 1985 Apr 01; 45(4):1611-20. PubMed ID: 3978629
    [Abstract] [Full Text] [Related]

  • 19. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
    Butler WB, Fontana JA.
    Cancer Res; 1992 Nov 15; 52(22):6164-7. PubMed ID: 1423259
    [Abstract] [Full Text] [Related]

  • 20. Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells.
    Cowan KH, Goldsmith ME, Levine RM, Aitken SC, Douglass E, Clendeninn N, Nienhuis AW, Lippman ME.
    J Biol Chem; 1982 Dec 25; 257(24):15079-86. PubMed ID: 7174686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.